Much Ado About a Mutation
Congenital Melanocytic Nevus With LINC00518 and Preferentially Expressed Antigen in Melanoma Positivity.
Bitar RA, Abrantes TF, Neale H, Schmidt BAR, Ganske IM, Hawryluk EB
Pediatric DermatologyIn the feed 18 Aug 2026, published online 17 Aug 2026, issue 2026 Aug 17, added to PubMed 18 Aug 2026
Topics: Skin cancer & tumorsMelanoma & molesChildren
Abstract
Small and medium sized congenital melanocytic nevi (CMN) have an overall low risk of malignant potential. This case demonstrates a pediatric patient with a small CMN positive for LINC00518 (LINC) and preferentially expressed antigen in melanoma (PRAME) on a non-invasive molecular test not yet validated in children. Although her nevus had not evolved, the availability of a molecular test and curiosity ultimately raised concern about this otherwise reassuring, stable CMN. This demonstrates the pitfalls of non-invasive testing in pediatric patients with CMN.
Abstract from PubMed
PMID 42608629 · DOI 10.1111/pde.70341